Belmont Capital, LLC Arcturus Therapeutics Holdings Inc. Transaction History
Belmont Capital, LLC
- $364 Million
- Q1 2024
A detailed history of Belmont Capital, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Belmont Capital, LLC holds 40,000 shares of ARCT stock, worth $858,000. This represents 0.37% of its overall portfolio holdings.
Number of Shares
40,000Holding current value
$858,000% of portfolio
0.37%Shares
1 transactions
Others Institutions Holding ARCT
# of Institutions
196Shares Held
26.7MCall Options Held
294KPut Options Held
318K-
Federated Hermes, Inc. Pittsburgh, PA4.7MShares$101 Million0.37% of portfolio
-
Black Rock Inc. New York, NY2.74MShares$58.8 Million0.0% of portfolio
-
State Street Corp Boston, MA1.96MShares$42 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.69MShares$36.2 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$29.8 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $570M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...